Literature DB >> 35125706

Intestinal Colonization Due to Carbapenem-Resistant Enterobacteriaceae Among Hematological Malignancy Patients in India: Prevalence and Molecular Charecterisation.

Amarjeet Kumar1, Sarita Mohapatra2, Raunak Bir2, Sonu Tyagi2, Sameer Bakhshi3, Manoranjan Mahapatra4, Hitender Gautam2, Seema Sood2, Bimal Kumar Das2, Arti Kapil2.   

Abstract

Faecal carriage of Carbapenem-resistant Enterobacteriaceae (CRE) is being observed as an important risk factor for bacteremia among patients with hematological malignancies. A prospective surveillance study was conducted among these patients to determine the gut colonization of CRE. Rectal/perianal swabs were collected to isolate CRE. Carbapenem resistance was detected by disk diffusion, modified-Hodge, Carba-NP test, and PCR for bla NDM-1, bla KPC, bla OXA-48, bla VIM, bla IMP genes. A total of 209 CRE isolates were identified from 151 patients. E. coli was the most common (83.2%) CRE identified, followed by Klebsiella spp. (9.6%). The majority of CRE were observed resistant to ertapenem (86%). bla NDM-1 was the most common gene (57.3%), followed by bla OXA-48 (37.8%). 26.8% isolates found to carry both bla NDM-1 and bla OXA-48 genes. CRE is increasingly observed to cause bacteremia among hematological malignancy patients due to increased colonization. Screening for gut CRE colonization is necessary to guide empirical therapy and apply infection control measures among these patients. © Indian Society of Hematology and Blood Transfusion 2021.

Entities:  

Keywords:  Carba-NP test; Carbapenem-resistant Enterobacteriaceae; Carbapenemases; Haematological malignancies; blaNDM-1 gene; blaOXA-48 gene

Year:  2021        PMID: 35125706      PMCID: PMC8804120          DOI: 10.1007/s12288-021-01415-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  29 in total

1.  Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.

Authors:  Marya D Zilberberg; Andrew F Shorr
Journal:  J Hosp Med       Date:  2013-09-10       Impact factor: 2.960

Review 2.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

Review 3.  The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment.

Authors:  Roy F Chemaly; Sarah Simmons; Charles Dale; Shashank S Ghantoji; Maria Rodriguez; Julie Gubb; Julie Stachowiak; Mark Stibich
Journal:  Ther Adv Infect Dis       Date:  2014-06

4.  Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate.

Authors:  M C Salomão; T Guimarães; D F Duailibi; M B M Perondi; L S H Letaif; A C Montal; F Rossi; A P Cury; A J S Duarte; A S Levin; I Boszczowski
Journal:  J Hosp Infect       Date:  2017-08-19       Impact factor: 3.926

5.  Colonization of the gut with Gram-negative bacilli, its association with neonatal sepsis and its clinical relevance in a developing country.

Authors:  Parijat Das; Arun K Singh; Titir Pal; Sudipta Dasgupta; T Ramamurthy; Sulagna Basu
Journal:  J Med Microbiol       Date:  2011-06-30       Impact factor: 2.472

6.  The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.

Authors:  Michael J Satlin; Stephen G Jenkins; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2014-01-23       Impact factor: 9.079

7.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.

Authors:  Karthikeyan K Kumarasamy; Mark A Toleman; Timothy R Walsh; Jay Bagaria; Fafhana Butt; Ravikumar Balakrishnan; Uma Chaudhary; Michel Doumith; Christian G Giske; Seema Irfan; Padma Krishnan; Anil V Kumar; Sunil Maharjan; Shazad Mushtaq; Tabassum Noorie; David L Paterson; Andrew Pearson; Claire Perry; Rachel Pike; Bhargavi Rao; Ujjwayini Ray; Jayanta B Sarma; Madhu Sharma; Elizabeth Sheridan; Mandayam A Thirunarayan; Jane Turton; Supriya Upadhyay; Marina Warner; William Welfare; David M Livermore; Neil Woodford
Journal:  Lancet Infect Dis       Date:  2010-08-10       Impact factor: 25.071

Review 8.  Global spread of Carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Thierry Naas; Laurent Poirel
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

9.  Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection.

Authors:  Emmanuel Montassier; Gabriel A Al-Ghalith; Tonya Ward; Stephane Corvec; Thomas Gastinne; Gilles Potel; Phillipe Moreau; Marie France de la Cochetiere; Eric Batard; Dan Knights
Journal:  Genome Med       Date:  2016-04-28       Impact factor: 11.117

10.  Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control.

Authors:  A P Magiorakos; K Burns; J Rodríguez Baño; M Borg; G Daikos; U Dumpis; J C Lucet; M L Moro; E Tacconelli; G Skov Simonsen; E Szilágyi; A Voss; J T Weber
Journal:  Antimicrob Resist Infect Control       Date:  2017-11-15       Impact factor: 4.887

View more
  1 in total

1.  Rectal and Tracheal Carriage of Carbapenemase Genes and Class 1 and 2 Integrons in Patients in Neurosurgery Intensive Care Unit.

Authors:  Ekaterina S Kuzina; Tatiana S Novikova; Evgeny I Astashkin; Galina N Fedyukina; Angelina A Kislichkina; Natalia V Kurdyumova; Ivan A Savin; Olga N Ershova; Nadezhda K Fursova
Journal:  Antibiotics (Basel)       Date:  2022-07-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.